← Research hub  ·  securities

IDXX · IDEXX Laboratories $510.46 +3.98 (+0.79%) 2026-SEP-18 12:48 EST

My allocationNot heldas of 2026-SEP-03 · allocation page ↗
Research: QT · SA · STK · FA1 mention
2026-JUL-16 · Chance Finucane · Thoughtful Money (Adam Taggart) · Positiveinsight · ▶ 49:50 · source page ↗$560.91

In short: Recent long-term-growth add: an "industrial" business selling niche, critically-important products that are a low share of the customer's cost → reliability + pricing power.

In plain English

IDEXX makes veterinary diagnostic products (tests and instruments for animal clinics). He describes it as an "industrial-style" business: it sells niche products that are essential to its customers but only a small slice of their total costs.

That combination — you must have it, but it's cheap relative to everything else you spend — gives IDEXX reliability and pricing power. It's a recent addition to the growth portfolio: a steady, high-quality compounder bought instead of chasing AI stocks.

49:50And as I promised, I just want to show folks specifically some of the things that Oxbow is adding to its portfolios right now. So is there anything you want to mention about any of these recent additions? — Yeah, I can just touch on it broadly. So in long-term growth, which is our stock strategy, the thing to take away from those three names, IDEXX is an industrial business that tries to just buy niche companies that are critically important products for their customers, but are a low portion of the

SOD $560.91

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.